Abstract
Abstract Steroid inhaler usage is the cornerstone of asthma management. This case report describes the development of central serous chorioretinopathy (CSCR) in a 69-year-old female following the use of Symbicort for the management of asthma. The association between inhaled corticosteroids and CSCR is discussed, highlighting the need for awareness among health-care providers. Further research is necessary to establish the pathogenicity of this rare condition and alternatives for patients in whom inhaled corticosteroids are essential to the control of their long-term condition.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
